Rhonda Tannenbaum

Ms. Rhonda Tannenbaum is Vice President-Business Development at Ontario Genomics Institute (Private Equity).
Ms. Tannenbaum joined OGI in June 2003.
Previously, she was a consultant with Trillium Therapeutics, which developed therapies that rebalance the immune system in conditions associated with abnormal and harmful immune responses.
Ms. Tannenbaum earned an MBA, with a focus on strategy, from the John Molson School of Business at Concordia University and an MSc in Marine Biology from the University of Tel-Aviv.